Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Community Health Worker Nutrition Self-Management Support for Cardio-Kidney-Metabolic Health (INTEGRATE-CHW)

30 ottobre 2026 aggiornato da: Dr. Janet Diaz Martinez, Florida International University

Integrating Tailored Medical Nutrition Therapy and Community Health Worker Support to Advance Cardio-Kidney-Metabolic Health

This study tests whether adding CHW support to usual nutrition care helps adults with type 2 diabetes, hypertension, or chronic kidney disease manage their diet and health. At Caridad Center, a free clinic in Palm Beach County, Florida, usual care includes medical nutrition therapy from a registered dietitian and medically tailored groceries. Many patients find it hard to keep up dietary changes because of limited nutrition knowledge, cooking skills, food costs, and cultural fit.

Two hundred adults will be randomly assigned to usual care or usual care plus INTEGRATE-CHW, a 12-week program of six sessions with a trained CHW. In each session the participant selects one or two goals from the dietitian's plan and builds an action plan with the CHW. The dietitian remains responsible for the nutrition plan. The study will compare nutrition self-efficacy, nutrition literacy, diet quality, food security, and clinical measures between groups at baseline and Week 12. It will also evaluate how well the program fits into routine clinic care.

Panoramica dello studio

Descrizione dettagliata

Dietitian-led MNT and medically tailored food programs improve diet quality and food security during active participation, but these gains often diminish once food delivery or counseling ends. Sustaining improvement requires ongoing behavioral reinforcement and self-management support that help patients adapt nutrition guidance to their cultural and household routines. This trial tests whether CHWs embedded in the dietitian's workflow can provide that reinforcement within routine care at a safety-net clinic.

The intervention is guided by Social Cognitive Theory, the Corbin and Strauss self-management framework, and Lorig and Holman's self-management skills. Self-efficacy serves as the central behavioral mechanism of change, operationalized through confidence-based goal setting, problem solving, and action planning. Enhanced self-efficacy is expected to improve adherence to dietary goals and, in turn, clinical cardio-kidney-metabolic indicators.

Aim 1 will determine the effect of INTEGRATE-CHW on behavioral outcomes. Aim 2 will examine preliminary effects on clinical outcomes. Aim 3 will evaluate implementation using mixed methods guided by RE-AIM and Proctor's framework, including semi-structured interviews with approximately 15 intervention participants and 5 staff (CHWs, registered dietitians, and clinic leads) exploring satisfaction, perceived burden, and workflow fit.

Analyses follow the intent-to-treat principle with two-sided tests (α = 0.05) and Benjamini-Hochberg false-discovery control. Between-group differences at Week 12 are estimated with analysis of covariance adjusting for baseline values. Behavioral models adjust for age, sex, language, baseline food insecurity, and CKD status. Clinical models adjust for age, sex, CKM profile, and medication classes (SGLT2 inhibitor, GLP-1 receptor agonist, ACE inhibitor/ARB, and statin use). Linear mixed-effects models are used for sensitivity analyses. Exploratory analyses test effect modification by baseline food insecurity, nutrition literacy level, and dominant CKM condition, and test whether changes in self-efficacy, literacy, or diet quality mediate changes in clinical indicators. A total of 200 participants (100 per arm) provides at least 80% power (α = 0.05) to detect a small-to-moderate effect (Cohen's d ≈ 0.35).

Tipo di studio

Interventistico

Iscrizione (Stimato)

200

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Jordan Program coordinator
  • Numero di telefono: 305-348-4720
  • Email: joquinta@fiu.edu

Luoghi di studio

    • Florida
      • Boynton Beach, Florida, Stati Uniti, 33472
        • Caridad Center, Inc.

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

18 anni e precedenti (Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria:

  • Adults aged 18 years or older receiving care at Caridad Center
  • Documented diagnosis of type 2 diabetes (HbA1c ≥ 6.5%), hypertension (systolic blood pressure ≥ 130 mmHg), or chronic kidney disease Stages 1-4 (eGFR 15-59 mL/min/1.73 m² regardless of albuminuria, or eGFR ≥ 15 mL/min/1.73 m² with albuminuria ≥ 30 mg/g)
  • Eligible for medical nutrition therapy and medically tailored groceries through -Caridad Center
  • Able to provide informed consent in English or Spanish

Exclusion Criteria:

  • Dialysis or advanced kidney failure (CKD Stage 5; eGFR < 15 mL/min/1.73 m²)
  • Pregnancy
  • Cognitive impairment precluding participation
  • Plans to relocate during the 12-week intervention

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Ricerca sui servizi sanitari
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: INTEGRATE-CHW

Usual care plus a 12-week CHW-delivered, nutrition-focused self-management support program: six sessions of approximately 60 minutes at Weeks 1, 3, 5, 7, 9, and 11, delivered in person or virtually by participant preference, and a Week 12 wrap-up aligned with the routine dietitian visit and laboratory review.

Trained CHWs deliver culturally tailored sessions using FlipChart visuals, pictorial goal cards, and recipe swaps. The curriculum covers diet and CKM links and home blood pressure and glucose monitoring (Session 1), diabetes (Session 2), hypertension (Session 3), CKD (Session 4), cardiometabolic integration (Session 5), and maintenance (Session 6). Participants select one to two goals from their dietitian's plan and build confidence-rated action plans. CHWs reinforce, but do not modify, dietitian guidance. Between sessions, CHWs provide reminder and follow-up contact by telephone or text message. Participants enter home blood pressure and glucose readings and goals into REDCap directly or with CHW assistance.

Comparatore attivo: Usual Care

Caridad Center standard care: individualized medical nutrition therapy from a registered dietitian approximately every three months and medically tailored groceries or meal boxes biweekly for 12 weeks.

Individualized medical nutrition therapy from a registered dietitian following the Academy of Nutrition and Dietetics' Nutrition Care Process, plus biweekly medically tailored groceries or meal boxes for 12 weeks.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change From Baseline in Nutrition Self-Efficacy Scale Score at Week 12
Lasso di tempo: Baseline and Week 12

5-item Nutrition Self-Efficacy Scale, which measures confidence in maintaining healthy eating behaviors despite common barriers. Interviewer-administered in English or Spanish.

Baseline and Week 12
Change From Baseline in Short Food Literacy Questionnaire (SFLQ) Score at Week 12
Lasso di tempo: Baseline and Week 12

12-item Short Food Literacy Questionnaire (SFLQ), which evaluates the ability to interpret nutrition information, read labels, and make balanced food choices. Interviewer-administered in English or Spanish.

Baseline and Week 12
Change From Baseline in Healthy Eating Index-2020 (HEI-2020) Total Score at Week 12
Lasso di tempo: Baseline and Week 12

Healthy Eating Index-2020 (HEI-2020) total score, derived from two 24-hour dietary recalls.

Baseline and Week 12

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change From Baseline in USDA Six-Item Food Security Module Score at Week 12
Lasso di tempo: Baseline and Week 12

USDA six-item food security module.

Baseline and Week 12
Change From Baseline in HbA1c (%) at Week 12
Lasso di tempo: Baseline and Week 12

Glycated hemoglobin (%), extracted from the electronic medical record.

Baseline and Week 12
Change From Baseline in Systolic Blood Pressure (mmHg) at Week 12
Lasso di tempo: Baseline and Week 12

Systolic blood pressure (mmHg), extracted from the electronic medical record.

Baseline and Week 12
Change From Baseline in Diastolic Blood Pressure (mmHg) at Week 12
Lasso di tempo: Baseline and Week 12

Diastolic blood pressure (mmHg), extracted from the electronic medical record.

Baseline and Week 12
Change From Baseline in Body Mass Index (kg/m²) at Week 12
Lasso di tempo: Baseline and Week 12

Body mass index (kg/m²), extracted from the electronic medical record.

Baseline and Week 12
Change From Baseline in Lipid Profile at Week 12
Lasso di tempo: Baseline and Week 12

Lipid profile, extracted from the electronic medical record.

Baseline and Week 12
Change From Baseline in eGFR (mL/min/1.73 m²) at Week 12
Lasso di tempo: Baseline and Week 12

eGFR (mL/min/1.73 m²), extracted from the electronic medical record.

Baseline and Week 12
Change From Baseline in Urinary Albumin-to-Creatinine Ratio (mg/g) at Week 12
Lasso di tempo: Baseline and Week 12

uACR (mg/g), extracted from the electronic medical record; log-transformed and reported as ratios of geometric means.

Baseline and Week 12

Altre misure di risultato

Misura del risultato
Misura Descrizione
Lasso di tempo
Feasibility: Proportion of Eligible Patients Who Enroll and Complete Follow-up
Lasso di tempo: Enrollment through Week 12 follow-up

Proportion of eligible patients who enroll and complete follow-up.

Enrollment through Week 12 follow-up
Reach: Demographic Comparability of Enrolled Participants With the Clinic's CKM Population
Lasso di tempo: Enrollment period

Demographic comparability between enrolled participants and the clinic's CKM population.

Enrollment period
Fidelity: Percentage of CHW Sessions Meeting All Required Elements
Lasso di tempo: Weeks 1-12

Percentage of CHW sessions meeting all required elements, assessed through CHW session checklists, direct observation, and periodic audio review.

Weeks 1-12
Acceptability: Theoretical Framework of Acceptability (TFA) Survey Score
Lasso di tempo: Week 12

Theoretical Framework of Acceptability (TFA) survey completed by intervention participants.

Week 12
Adoption: Proportion of RDs, CHWs, and Food Partners Delivering the Program as Intended
Lasso di tempo: Up to 21 months (intervention delivery period)

Proportion of participating registered dietitians, CHWs, and food partners delivering the program as intended.

Up to 21 months (intervention delivery period)
Incremental Cost per Participant (US Dollars)
Lasso di tempo: 12 weeks

Estimated from staff time, session duration, and supply costs, with cost per unit outcome.

12 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Janet Diaz Martinez, Florida International University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

15 luglio 2027

Completamento primario (Stimato)

30 aprile 2029

Completamento dello studio (Stimato)

14 gennaio 2030

Date di iscrizione allo studio

Primo inviato

26 ottobre 2026

Primo inviato che soddisfa i criteri di controllo qualità

30 ottobre 2026

Primo Inserito (Effettivo)

5 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

5 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

30 ottobre 2026

Ultimo verificato

1 ottobre 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

SÌ

Descrizione del piano IPD

Following publication of primary findings, de-identified datasets, data dictionaries, and codebooks will be made available through FIU's secure repository. Shared files will exclude personally identifiable information and contain only derived variables.

Periodo di condivisione IPD

Following publication of primary findings; data will remain available for at least five years after project completion or publication of final results, whichever occurs later.

Criteri di accesso alla condivisione IPD

De-identified datasets, data dictionaries, codebooks, and analytic code will be available to researchers through FIU's institutional repository and, where applicable, the USDA Ag Data Commons, under FIU's Open Data Policy for research and educational re-use with attribution. Shared files will exclude personally identifiable information and contain only derived variables. Requests for restricted materials, such as qualitative transcripts, will require a data-use agreement and ethics approval.

Tipo di informazioni di supporto alla condivisione IPD

  • CODICE_ANALITICO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi